IMTH — Innovative Medtech Share Price
Last trade - 00:00- $21.53m
- $22.28m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Oct | Unit | 2010 | 2011 | 2012 | 2013 | 2014 | 2015E | 2016E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.65 | 0.67 | n/a | n/a | n/a | n/a | n/a | -100% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Innovative MedTech, Inc is a provider of health and wellness services. The Company operates in two divisions: technology and devices and Adult Day Services. The Company’s technology and devices division has signed a distribution agreement with two products: a high detection vein visualization device and an Oral Thrush product, and the Company’s wholly owned subsidiary SarahCare, an adult day care franchisor with approximately 25 centers (1 corporate and 24 franchise locations) located in 13 states. SarahCare offers seniors daytime care and activities focusing on meeting their physical and medical needs on a daily basis and ranging from nursing care to salon services and providing meals, to offering engaging and enriching activities to allow them to continue to lead active and engaged lives.
Directors
- Last Annual
- October 31st, 2014
- Last Interim
- October 31st, 2014
- Incorporated
- April 21st, 2017
- Public Since
- May 8th, 2007
- No. of Employees
- 1
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 52,518,963
- Address
- 2310 York St, Suite 200, BLUE ISLAND, 60406
- Web
- Phone
- +1 7089259424
- Auditors
- Accell Audit & Compliance, P.A
Upcoming Events for IMTH
Similar to IMTH
All American Gold
Pink Sheets on Nasdaq
American Education Center
Pink Sheets on Nasdaq
Arem Pacific
Pink Sheets on Nasdaq
Axia International
Pink Sheets on Nasdaq
Un Monde International
Pink Sheets on Nasdaq
FAQ
As of Today at 21:19 UTC, shares in Innovative Medtech are trading at $0.41. This share price information is delayed by 15 minutes.
Shares in Innovative Medtech last closed at $0.41 and the price had moved by -51.48% over the past 365 days. In terms of relative price strength the Innovative Medtech share price has underperformed the S&P500 Index by -55.01% over the past year.
There is no consensus recommendation for this security.
Find out moreInnovative Medtech does not currently pay a dividend.
Innovative Medtech does not currently pay a dividend.
Innovative Medtech does not currently pay a dividend.
To buy shares in Innovative Medtech you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.41, shares in Innovative Medtech had a market capitalisation of $21.53m.
Here are the trading details for Innovative Medtech:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: IMTH
Based on an overall assessment of its quality, value and momentum Innovative Medtech is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Innovative Medtech. Over the past six months, its share price has outperformed the S&P500 Index by +19.36%.
As of the last closing price of $0.41, shares in Innovative Medtech were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Innovative Medtech PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.41.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Innovative Medtech's management team is headed by:
- Michael Friedman - CHM
- Jay Odintz - IND